@entity788 following XXXX Therapy: A Report of Three Cases.

@entity1 @entity1088 @entity788 @entity2298 @entity1037
CONTEXT: Atypical antipsychotic agents ( @entity1088 , @entity1037 ) have been linked to metabolic effects and acute @entity788 . CASE REPORT: We reviewed the inpatient and outpatient records of three @entity1 who developed acute @entity788 while being treated with @entity1037 . The mean age of the @entity1 was 37.7 years (range 18-54 years, 2 female, 1 male). No alternative cause of acute @entity788 was found in two of the three @entity1 . In the remaining @entity1 , @entity1037 may have contributed to acute @entity788 in the setting of @entity2298 . @entity1037 was discontinued in all instances. Over a mean follow-up of 14 months, one @entity1 has had a relapsing course, but the remaining two @entity1 have been symptom free without recurrence of acute @entity788 . CONCLUSIONS: Our case series adds further support to the potential link between @entity1037 use and acute @entity788 . Close monitoring of metabolic parameters is suggested in @entity1 treated with @entity1037 . Alternative antipsychotic agents should be considered in @entity1 at high risk for @entity788 .
